Bruker Corporation (BRKR)
| Market Cap | 10.51B |
| Revenue (ttm) | 1.99B |
| Net Income (ttm) | 157.80M |
| Shares Out | 153.40M |
| EPS (ttm) | 1.32 |
| PE Ratio | 52.48 |
| Forward PE | 39.37 |
| Dividend | $0.12 |
| Dividend Yield | 0.17% |
| Trading Day | May 7 |
| Last Price | $69.33 |
| Previous Close | $68.20 |
| Change ($) | 1.13 |
| Change (%) | 1.66% |
| Day's Open | 68.42 |
| Day's Range | 68.00 - 70.08 |
| Day's Volume | 359,317 |
| 52-Week Range | 36.73 - 71.28 |
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the following virtual conferences: BofA Securities 2021 Health Care Conference Tuesday, May 11...
Bruker (BRKR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Bruker's (BRKR) robust performances across segments and geographies manage to drive its Q1 sales despite pandemic-led business challenges.
Bruker Corp (NASDAQ: BRKR) reported first-quarter FY21 revenue growth of 30.8% year-on-year to $554.7 million, beating the analyst consensus of $513.06 million. Revenue increased by 23.8% on an organic ...
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced financial results for its first quarter ended March 31, 2021. First Quarter 2021 Financial Results Bruker's revenues ...
Bruker's (BRKR) revenue improvement in the first quarter is likely to have been boosted by robust performance by all three of its BSI groups.
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced preliminary revenue for the first quarter ended March 31, 2021 in a range of $549 - $554 million, representing report...
Indexes Make Up Lost Ground; Strong Moves In Nvidia and Yeti, Bruker Sets Up
Indexes make up lost ground; Strong moves in Nvidia and Yeti, Bruker sets up. Investor's Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data,...
Investors continue to be optimistic about Bruker (BRKR) on its slew of product launches and potential in the BSI Nano Group.
BILLERICA, Mass.--(BUSINESS WIRE)--Gigahertz-class NMR Opens New Scientific Windows on Functional Structural Biology in Neurodegenerative Disease and Aging Research
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Makes Routine Magnetic Resonance Spectroscopy More Broadly Accessible for Chemical Analysis Outside Central Labs
NEW YORK--(BUSINESS WIRE)--Bruker Light-Sheet Microscopes at Major Comprehensive Cancer Center
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock?
SAN JOSE, Calif. & BOSTON--(BUSINESS WIRE)--Acuity Spatial Genomics Announces Formation to Open up New Frontiers for in situ, Spatial 3D Genomics
Bruker Corp (BRKR) has seen solid earnings estimate revision activity over the past two months, and belongs to a strong industry as well.
CHARLESTON, S.C., March 10, 2021 /PRNewswire/ -- GlycoPath Inc., the developer of advanced bioanalytical assays based on its proprietary GlycoTyperTM immunoaffinity technology, announced the closing of ...
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Announces New Results in Deep, Unbiased Plasma Proteomics, PaSER 1.1 Software and New Cross-linking Consumables at US HUPO 2021
MUNICH--(BUSINESS WIRE)--Nature Communications Publication by Mann & Theis Groups Harnesses the Benefits of Large-scale Peptide Collisional Cross Section (CCS) Measurement
Within Bruker's (BRKR) Nano Group Semiconductor metrology revenues have been steady with order rates improving as semi metrology equipment markets are witnessing a rebound.
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation to Present at Investor Conferences
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Announces Quarterly Dividend
Bruker's (BRKR) revenues increased 4.6% year over year to $627.5 million but declined 0.4% organically in fourth-quarter fiscal 2020.
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Reports Fourth Quarter and Fiscal Year 2020 Financial Results
Bruker (NASDAQ:BRKR) unveils its next round of earnings this Tuesday, February 16. Get prepared with Benzinga's ultimate preview for Bruker's Q4 earnings.
Bruker (BRKR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Bruker (BRKR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bruker (BRKR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Announces Date and Time of Fourth Quarter 2020 Earnings Release and Webcast
CAMBRIDGE & WETHERBY, England & BILLERICA, Mass.--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, announces that it has entered into a collaboratio...
4 Stocks to Watch on Rising Demand for Scientific Instruments
BOSTON, United States & REGENSBURG, Germany--(BUSINESS WIRE)--NMR diagnostics company numares and Bruker Corporation sign agreement to enable advanced metabolomics-based, AI driven clinical diagnostics.
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation to Present at the 39th Annual J.P. Morgan Healthcare Conference
BILLERICA, Mass. & ODENSE, Denmark--(BUSINESS WIRE)--Bruker and Evosep Announce Major Progress in Unbiased, Quantitative True Single-cell Proteomics
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Introduces MBT Sepsityper® Kit US IVD for Rapid and Affordable Identification of over 400 Microorganisms from Positive Blood Cultures
Bruker's (BRKR) winter four-plex panel is expected to facilitate diagnosis and patient management by facilitating the use of saliva samples as well.
NEHREN, Germany--(BUSINESS WIRE)--Bruker Launches FluoroType® SARS-CoV-2/Flu/RSV PCR Panel in Europe with CE-IVD Mark
Bruker (BRKR) is optimistic about maintaining a robust product portfolio along with its continued COVID-19-led progress.
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock?
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation to Participate in the Jefferies Virtual London Healthcare Conference
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Announces Quarterly Dividend
Bruker's (BRKR) third-quarter 2020 results reflect dismal performances by two of the reporting segments and geographies due to coronavirus-led business disruptions.
Bruker Corporation (BRKR) CEO Frank Laukien on Q3 2020 Results - Earnings Call Transcript
Bruker (BRKR) delivered earnings and revenue surprises of 27.27% and 5.27%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Reports Third Quarter 2020 Financial Results
On Monday, November 02, Bruker (NASDAQ: BRKR) will release its latest earnings report. Benzinga's outlook for Bruker is included in the following report.
Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MADISON, Wisc.--(BUSINESS WIRE)--Bruker Introduces Vutara™ VXL Best-in-Class Super-Resolution Microscope and Spatial Biology Analysis Capabilities
About BRKR
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; analytical and process analysis instruments and solutions based on in... [Read more...]
| Industry Medical Devices | IPO Date Aug 4, 2000 |
| CEO Frank Laukien | Employees 7,400 |
| Stock Exchange NASDAQ | Ticker Symbol BRKR |
Financial Performance
In 2020, Bruker's revenue was $1.99 billion, a decrease of -4.11% compared to the previous year's $2.07 billion. Earnings were $157.80 million, a decrease of -19.98%.
Analyst Forecasts
According to 13 analysts, the average rating for Bruker stock is "Buy." The 12-month stock price forecast is 72.17, which is an increase of 4.10% from the latest price.